1B. Pharm Student, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanashi, Uttar Pradesh, India
2Research Mentor, Accendere Knowledge Management Services, CL Educate Ltd., New Delhi
*Corresponding author: S. Parthasarathi, E-mail: chemsarathi@gmail.com, Mob.: +91-8892382659
Online published on 26 September, 2019.
This report provides latest information and different ways and methods for diagnosing and treating Alzheimer's disease (AD). It also includes history, prevalence and incidence rates, and therapeutic drugs for AD. In therapeutic research, many drugs, namely tramiprosate, tarenflurbil, bapineuzimab, donepezil and memontine etc are developed to prevent the formation of plaques and nuerofibrillary tangles which are the major causes for Alzheimer's disease. Many organizations and committees are still providing funds and promoting research on diagnosis and treatment methods for AD. The prevalence rate is increasing exponentially against age and it is increasing rapidly after 65 years of age, whereas there are 24.2 million people suffering with AD and in 4.2 million persons the disease is getting incident every year.
Alzheimer's disease, Treatment, Biomarkers, Neuropathology, Epidemiology
